Preparing for 2020 launch of novel digital PCR systems with fully integrated workflow and menu of QIAGEN assays, advantages of improved multiplexing, throughput and scalability Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the development of a range of next-generation systems for digital polymerase chain reaction (digital PCR […]

Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options Redwood City, California, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer […]

Launch of Byos® Platform Cements Company as Leader of Biologics Characterization Software Protein Metrics provides tools that allow our customers to pull milestones forward. CUPERTINO, CALIF. Protein Metrics Inc., a premier provider of mass spectrometry software for protein characterization, announced today a fifth consecutive year of record revenue and bookings across all customer segments in […]

SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its Application Programming Interface (Twist API or TAPI) available for all […]

Agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology This collaboration reflects an initial phase of a multi study plan in the field of ophthalmology Further step to establish AYOXXA LUNARISTM system as the standard for […]

SAN FRANCISCO — Today Color announced an initiative to help build the foundation for the first mainstream application of whole genome sequencing in clinical care, through the use of polygenic risk scores. Polygenic risk scoring can help clinicians identify populations who are at risk for diseases such as cancer and heart disease in order to optimize prevention […]

 –Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – Paragon Genomics, Inc., a […]

Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis ST. LOUIS–PierianDx, a leading clinical genomics informatics company, today announced a strategic, non-exclusive, multi-year partnership with Illumina, Inc. to provide a variant interpretation and reporting solution based on PierianDx’s Clinical Genomics […]

CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ urine collection technology expands molecular collection portfolio and advances OraSure’s expertise in non-invasive sampling BETHLEHEM, Pa. — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today […]

San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, […]